The Outcomes of Surgery and Chemoradiotherapy for Temporal Bone Cancer

Abstract

Patients with T1-2 benefited from surgical intervention without significant morbidity or mortality. Our findings also suggested that definitive CRT might be appropriate as the first-line treatment for T3-4, especially in cases with unresectable tumors.